UBS AG is offering $786,000 of Phoenix Autocallable Notes with Memory Interest linked to IREN Limited common stock and due October 6, 2027. Investors face contingent payments, possible early Redemption and unsecured exposure, while UBS says fees and pricing factors may reduce economic value and affect secondary-market prices.
Key Highlights
- J.P. Morgan Securities LLC and UBS Investment Bank are serving as Placement agents for the notes.
- Certain Fiduciary accounts may purchase the securities for $990.00 per $1,000 principal amount.
- UBS says the offering involves conflicts of interest under FINRA Rule 5121.
UBS AG is offering $786,000 of Phoenix Autocallable Notes with Memory Interest tied to the common stock of IREN Limited (NASDAQ: IREN). The notes mature on October 6, 2027, and are structured as unsubordinated, unsecured obligations of UBS AG. Their payments and redemption depend on the performance of the underlying stock.
Contingent Payments and Automatic Calls
Each note can pay contingent interest on an interest payment date when IREN Limited’s closing stock price reaches or exceeds the stated interest barrier on an observation date. Any unpaid contingent interest can be carried forward and paid later if the condition is met. A missed condition means no contingent interest for that payment date. UBS AG will automatically call the notes early when the applicable closing-price condition is satisfied.
Pricing, Fees and Valuation Conditions
The public issue price is $1,000 per note. The Underwriting discount is $10.00 per $1,000 principal amount, producing total underwriting discounts of $7,860 and proceeds to UBS of $778,140. UBS says the issue price exceeds the estimated initial value because it includes underwriting, hedging, issuance and other costs, as well as projected profits. The estimated initial value is theoretical, and any secondary-market price may differ materially.
FAQs
Q: What factors determine the estimated initial value of UBS AG’s IREN notes?
A: UBS’s internal pricing models consider IREN’s price and volatility, expected dividends, interest rates, the notes’ term and UBS’s internal funding rate.
Q: Are UBS AG’s IREN-linked notes insured deposits?
A: No. The notes are debt obligations of UBS AG, not bank deposits, and they are not insured by the Federal Deposit Insurance Corporation or another governmental agency.
Q: What approval is needed for discretionary-account sales?
A: UBS Securities LLC may not sell the notes to an account under its discretionary authority without the account holder’s prior specific written approval.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.